000 01162 a2200373 4500
005 20250513235636.0
264 0 _c20010521
008 200105s 0 0 eng d
022 _a0025-6196
024 7 _a10.4065/76.4.353
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aElliott, D S
245 0 0 _aMedical management of overactive bladder.
_h[electronic resource]
260 _bMayo Clinic proceedings
_cApr 2001
300 _a353-5 p.
_bdigital
500 _aPublication Type: Comment; Editorial
650 0 4 _aAge Distribution
650 0 4 _aAged
650 0 4 _aCholinergic Antagonists
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPrognosis
650 0 4 _aRisk Factors
650 0 4 _aUrinary Bladder, Neurogenic
_xdiagnosis
650 0 4 _aUrinary Incontinence, Stress
_xdiagnosis
650 0 4 _aUrination Disorders
_xdiagnosis
700 1 _aLightner, D J
700 1 _aBlute, M L
773 0 _tMayo Clinic proceedings
_gvol. 76
_gno. 4
_gp. 353-5
856 4 0 _uhttps://doi.org/10.4065/76.4.353
_zAvailable from publisher's website
999 _c11256421
_d11256421